JAMA 13 July 2011 Vol 306 Unusually, I couldn’t find anything to report on from JAMA this week. Last week, its new editor, Howard Bauchner, promised us a new vision […]
Richard Lehman’s weekly review of medical journals
Richard Lehman’s journal review – 11 July 2011
JAMA 6 July 2011 Vol 305 45 Of all the great writers, only Chekhov captures exactly the balance of good and evil in rural life. Before his fame as a […]
Richard Lehman’s journal review – 4 July 2011
NEJM 30 June 2011 Vol 364 2483 The world of African emergency medicine is one which many noble British GPs have visited, but I alas am not of their number. […]
Richard Lehman’s journal review – 27 June 2011
JAMA 22 June 2011 Vol 305 2525 Our understanding of the causes of the syndrome we label type 2 diabetes comes in dribs and drabs, and this study of the […]
Richard Lehman’s journal review – 20 June 2011
JAMA 15 June 2011 Vol 305 2419 Here is a study which may have major resource implications for you and your commissioning group, because it seems to show that there […]
Richard Lehman’s journal review – 13 June 2011
JAMA 8 June 2011 Vol 305 2295 Ovarian cancer almost always presents too late for a cure, so screening asymptomatic women must offer our best chance of reducing its high […]
Richard Lehman’s journal review – 6 June 2011
JAMA 1 June 2011 Vol 305 2184 Diabetes is a state of increased risk for many things, including fractures. The most striking thing I learnt from this study is that […]
Richard Lehman’s journal review – 31 May 2011
JAMA 25 May 2011 Vol 305 2071 Idiopathic sudden sensorineural hearing loss: now that’s the kind of medical label I can do business with – the kind that tells you […]
Richard Lehman’s journal review – 23 May 2011
JAMA 18 May 2011 Vol 305 1969 “Gastroesophageal reflux disease (GERD) is a chronic, relapsing disease with symptoms that have negative effects on daily life.” Actually it only became a […]
Richard Lehman’s journal review – 16 May 2011
JAMA 11 May 2011 Vol 305 1863 It’s hard to think of any physiological rationale for trying out a bolus dose of epoetin alfa following successful percutaneous intervention for myocardial […]